PositiveID Urges Digital Angel’s Board of Directors to Call a Special Meeting to Consider the Offer DELRAY BEACH, Fla. – PositiveID Corporation (“PositiveID” or the “Company”) (Nasdaq:PSID) commented today on Digital Angel Corporation’s (“DIGA”) (Nasdaq:DIGA) response to the Company’s proposal to acquire all of the outstanding common stock of DIGA through a merger transaction. Prior […]
SO. ST. PAUL, MN – Digital Angel (NASDAQ: DIGA), an advanced technology company in the field of animal identification and emergency identification solutions, today confirmed that it has received an unsolicited, non-binding proposal from PositiveID Corporation (NASDAQ: PSID) that, subject to due diligence and other unstated conditions, PSID is prepared to make an offer to […]
Complementary Technologies Would Create New Revenue Opportunities and Leader in Unique Medical and Veterinary Products Including Rapid Medical Testing for Humans, Animals and Food Safety Applications Merger is Expected to be Accretive to PositiveID Stockholders With $35-$40 Million in Combined Revenue DELRAY BEACH, Fla. – PositiveID Corporation (“PositiveID” or the “Company”) (Nasdaq:PSID) announced today that […]
AITBIOTECH Pte Ltd, a Singapore-based company, is a leading provider of Genomic Services and Molecular Diagnostic kits to the research, healthcare and biomedical industries in Singapore and Asia. 1. AITBIOTECH Pte Ltd of Singapore is pleased to announce the signing of several Molecular Diagnostic (MDx) licenses from Exploit Technologies Pte Ltd. The licenses are mainly […]
AUSTIN, Texas – Vermillion, Inc. (Nasdaq: VRML), a molecular diagnostics company, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent entitled “B2-microglobulin as a biomarker for peripheral artery disease” to the Company. The patent claims are directed to biomarker combinations that include B2-microglobulin for […]
SAN DIEGO – TriLink BioTechnologies, Inc. (TriLink) announced that it has signed a licensing agreement with Biofortuna Ltd. (Biofortuna) for use of CleanAmp™ dNTPs in Biofortuna’s freeze dried in vitro diagnostic PCR kits. Biofortuna is developing a range of unique HLA diagnostic kits which will address the transplantation, blood grouping, disease identification and pharmacogenetic markets. […]
BOSTON, Massachusetts – At the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Bruker Daltonics Inc. today announced the introduction of the new MALDI Sepsityper™ Kit for the rapid identification of microorganisms from positive blood culture bottles, using Bruker’s industry-leading MALDI Biotyper solution. The MALDI Biotyper has obtained the IVD-CE Mark, and is currently […]
Basel – Flexible “Intelligent LabPower” system helps labs increase efficiency, lets them reconfigure modules for changing needs Roche Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the cobas® 8000 modular analyzer series, a Serum Work Area solution designed for diagnostic laboratories […]
VANCOUVER, British Columbia – Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) today announced that the Company is taking steps to strategically refocus its resources and has implemented a company-wide cost-cutting initiative. As a result, the Company is expecting expense reductions of approximately $2 million in 2011 based on current sales levels. This $2 million savings […]
ROCKVILLE, Maryland and SEOUL, Korea – Seegene today announced its successful initial public offering on the KOSDAQ (Korea Securities Dealers Automated Quotations). The company sold 636,500 shares for USD 26.16 (WON 30,500) each, raising USD 16.6 million and giving Seegene a market capitalization of USD 167 million. The company plans to invest the fresh capital […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
